Lead oversight CRA for Quality Control Visits (RE-34268946)

We are seeking a dynamic individual to join our team as a Lead Oversight CRA for Quality Control Visits. In this role, you will play a pivotal part in ensuring the success of our international Phase III Oncology study.

Why Join Us:

• Impactful Work: Be at the forefront of innovative Oncology research, contributing directly to the advancement of medical science.
• Global Exposure: Travel the world as you conduct sponsor site quality oversight visits across the globe, working with diverse teams and cultures.
• Professional Growth: Gain valuable experience in clinical trial oversight and risk management, with opportunities for advancement and development.
• Collaborative Environment: Work alongside industry experts and leaders, fostering a culture of teamwork, support, and continuous learning.

Key Responsibilities:

• Conduct sponsor site quality oversight visits globally, ensuring compliance with regulatory standards.
• Collaborate with cross-functional teams to address trial oversight issues and develop risk mitigation strategies.
• Build strong relationships with internal and external stakeholders to enhance study execution and quality.
• Stay updated on emerging Oncology drug development practices, contributing to the success of our research initiatives.

Skills and Qualifications:

• Passion for Excellence: Demonstrated ability to deliver results with quality and within agreed timelines.
• Global Mindset: Ability to work effectively in a diverse, international environment, understanding cultural nuances and differences.
• Leadership Potential: Experience mentoring junior staff and strong interpersonal skills.
• Innovative Thinking: Proactive approach to problem-solving and risk management, with a drive for continuous improvement.

Required Qualifications:

• Bachelor's degree in a science-related discipline, with a proven track record in ICH-GCP and relevant standards.
• Minimum 10 years of clinical trial experience, including Oncology Phase 2-3 trials.
• EU residency and willingness to travel approximately 50%, including international travel.